Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Nonalcoholic Fatty Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03826381
What this trial is testing

NAFLD Among Patients With Type 2 Diabetes and CKD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney DiseasesType2 Diabetes
Rigshospitalet, Denmark 100
Not applicableEnrolling By InvitationNCT06519448
What this trial is testing

Reducing Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesDiabetes Mellitus, Type 2+1 more
Military University Hospital, Prague 30
Not applicableLooking for participantsNCT06701968
What this trial is testing

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisMyocardial Infarction+3 more
Uppsala University 150
Not applicableUnknownNCT06098417
What this trial is testing

Biomarkers in the Diagnosis and Prognosis of NAFLD

Who this might be right for
NAFLDObesityLiver Fibrosis+1 more
University of Trieste 500
Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Testing effectiveness (Phase 2)Looking for participantsNCT04501406
What this trial is testing

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida 166
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Not applicableLooking for participantsNCT06890169
What this trial is testing

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Who this might be right for
Obesity and Type 2 DiabetesNAFLD - Non-Alcoholic Fatty Liver DiseaseHypertension+2 more
Changi General Hospital 120
Post-approval studies (Phase 4)Study completedNCT02649465
What this trial is testing

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Kanazawa University 40
Not applicableStudy completedNCT04509245
What this trial is testing

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver, Nonalcoholic
German Diabetes Center 24
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Not applicableUnknownNCT02459496
What this trial is testing

Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus

Who this might be right for
Type 2 DiabetesNAFLDObesity+2 more
German Institute of Human Nutrition 200
Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT06005012
What this trial is testing

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Who this might be right for
Fibrosis, LiverType 2 Diabetes Mellitus in ObeseNon-Alcoholic Fatty Liver Disease
University of California, San Diego 120
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableStudy completedNCT03847116
What this trial is testing

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLight-to-moderate Alcohol ConsumptionType2 Diabetes Mellitus
Ningbo No. 1 Hospital 14,014
Not applicableStudy completedNCT03447964
What this trial is testing

Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Groupe Hospitalier Pitie-Salpetriere 128
Not applicableUnknownNCT05971082
What this trial is testing

Risk Factors for Advanced Fibrosis Among FLD Patients

Who this might be right for
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Helsinki University Central Hospital 1,000
Next Page